Science Explorer Interactive view Map
Company · San Diego · United States

Plex Pharmaceuticals (United States)

plexpharma.comROR OpenAlex
World rank, all time
#24,504
of 42,892
Rank in United States
#5,260
of 8,685
Research works
130
▼ 15% vs 2013–17
Citations
4.3k
33.3 per fractional work
Top-10% rate
10.8%
record average 16.5%
Open access
28%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.82× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 2.01× its world share, 0 worksImmunology and Micro…Neuroscience: 2.32× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.23× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.13× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.76× its world share, 0 worksEarth and Planetary …Engineering: 0.20× its world share, 0 worksEngineeringHealth Professions: 0.08× its world share, 0 worksHealth ProfessionsMedicine: 1.82× its world share, 5 worksMedicineNursing: 1.62× its world share, 0 worksNursingArts and Humanities: 0.41× its world share, 0 worksArts and Humanities1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.2×. Every wedge is a field page.

Who are the top researchers at Plex Pharmaceuticals (United States)?

Ranked on the composite score, Ganapathi R. Revankar lead among researchers whose main affiliation is Plex Pharmaceuticals (United States).

  1. 1 Ganapathi R. Revankar United States · #138,077 worldwide 195 citations · 41 works
All ranked researchers at Plex Pharmaceuticals (United States)

Which keywords describe research at Plex Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Therapeutic Targets, Cancer Therapy, Genomic Stability, Antiretroviral Therapy, DNA Structure, G-Quadruplexes, Gene Therapy and Self-Assembly.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Therapeutic Targets10▲ 32×3 topics
  2. Cancer Therapy9▲ 11×13 topics
  3. Genomic Stability8▲ 69×2 topics
  4. Antiretroviral Therapy8▲ 26×4 topics
  5. DNA Structure8▲ 95×1 topic
  6. G-Quadruplexes8▲ 95×1 topic
  7. Nanoparticles7▲ 4.3×5 topics
  8. Gene Therapy7▲ 20×4 topics
  9. Inflammation7▲ 2.2×16 topics
  10. Self-Assembly6▲ 13×4 topics
  11. Cancer6▲ 3.4×21 topics
  12. Immune Response6▲ 7.7×10 topics
  13. Biosensors6▲ 8.3×1 topic
  14. DNA nanotechnology6▲ 46×1 topic
  15. Tumor Microenvironment6▲ 13×6 topics
  16. Vaccine5▲ 10.0×10 topics
  17. RNA Interference5▲ 35×1 topic
  18. siRNA Delivery5▲ 52×1 topic
  19. Glycosylation5▲ 17×3 topics
  20. Hepatotoxicity5▲ 49×2 topics
  21. Synthesis5▲ 6.2×7 topics
  22. Drug Resistance5▲ 11×5 topics
  23. Infection4▲ 12×4 topics
  24. Adverse Effects4▲ 40×2 topics
  25. HIV Infection4▲ 26×1 topic
  26. Integrase Inhibitors4▲ 77×1 topic
  27. Antiviral Therapy4▲ 20×3 topics
  28. Biological Evaluation4▲ 23×4 topics
  29. Drug Discovery4▲ 7.2×5 topics
  30. Innate Immunity4▲ 7.9×6 topics
  31. Vaccine Development4▲ 9.1×5 topics
  32. Monoclonal Antibodies4▲ 19×3 topics
  33. HIV3▲ 22×2 topics
  34. Transcriptional Regulation3▲ 11×5 topics
  35. Cancer Immunotherapy3▲ 18×3 topics
  36. Cytomegalovirus3▲ 53×1 topic
  37. PET Imaging3▲ 12×5 topics
  38. Transplant Recipients3▲ 29×1 topic
  39. Therapeutic Antibodies3▲ 19×2 topics
  40. Immune Activation3▲ 25×2 topics

Which research topics does Plex Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Peptidase Inhibition and Analysis, Cancer Mechanisms and Therapy, Chromatin Remodeling and Cancer and Ubiquitin and proteasome pathways.

Peptidase Inhibition and…1Peptidase Inhibition and Analysis: 1 fractional worksCancer Mechanisms and Th…1Cancer Mechanisms and Therapy: 1 fractional worksChromatin Remodeling and…1Chromatin Remodeling and Cancer: 1 fractional worksUbiquitin and proteasome…1Ubiquitin and proteasome pathways: 1 fractional worksProtein Degradation and Inhibitors: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksMelanoma and MAPK Pathways0Melanoma and MAPK Pathways: 0 fractional worksGene expression and canc…0Gene expression and cancer classification: 0 fractional worksBioinformatics and Genom…0Bioinformatics and Genomic Networks: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional works
OncologyPathology and Forensic MedicineMolecular BiologyPulmonary and Respiratory Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Peptidase Inhibition and Analysis Oncology 1 works
  2. 2 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
  3. 3 Chromatin Remodeling and Cancer Molecular Biology 1 works
  4. 4 Ubiquitin and proteasome pathways Molecular Biology 1 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 0 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  7. 7 Melanoma and MAPK Pathways Molecular Biology 0 works
  8. 8 Gene expression and cancer classification Molecular Biology 0 works
  9. 9 Bioinformatics and Genomic Networks Molecular Biology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.7%not open72.3%

World: 28% of research is openly available.

with international co-authors12.2%domestic only87.8%

World: 19% is written across borders.

How has Plex Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 15% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.